T. Rowe Price Investment Management, Inc. Arrowhead Pharmaceuticals, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $158 Billion
- Q2 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 2,560,833 shares of ARWR stock, worth $49.6 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
2,560,833
Previous 1,758,883
45.59%
Holding current value
$49.6 Million
Previous $50.3 Million
32.31%
% of portfolio
0.04%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding ARWR
# of Institutions
295Shares Held
92.3MCall Options Held
1.33MPut Options Held
549K-
Black Rock Inc. New York, NY15.7MShares$304 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$236 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.89MShares$172 Million3.15% of portfolio
-
State Street Corp Boston, MA5.84MShares$113 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.14MShares$80.1 Million2.11% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.05B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...